Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Raymond James Downgrades Sunstone Hotel Invts to Underperform

Raymond James Downgrades Sunstone Hotel Invts to Underperform

Raymond James analyst William Crow downgrades Sunstone Hotel Invts (NYSE:SHO) from Market Perform to Underperform.

byBenzinga Newsdesk

December 9, 2022

1 minute read

Raymond James analyst William Crow downgrades Sunstone Hotel Invts (NYSE:SHO) from Market Perform to Underperform.

Morgan Stanley Initiates Coverage On RXO with Equal-Weight Rating, Announces Price Target of $20

By Benzinga Newsdesk

December 9, 9:37 AM

Morgan Stanley analyst Ravi Shanker initiates coverage on RXO (NYSE:RXO) with a Equal-Weight rating and announces Price Target of $20.

RXO

Evaxion Announces Initial Phase 2 Clinical Data On Its Personalized Cancer Vaccine EVX-01

By Benzinga Newsdesk

October 31, 11:17 AM

Initial EVX-01 Phase 2 data confirms the strong Phase 1 resultsAfter undergoing EVX-01 treatment, a significant and continuous tumor reduction was observed in a metastatic melanoma patient with initial progressive

EVAX

HC Wainwright & Co. Assumes Elevation Oncology at Buy, Announces Price Target of $7.5

By Benzinga Newsdesk

September 19, 7:47 AM

HC Wainwright & Co. analyst Gobind Singh assumes Elevation Oncology (NASDAQ:ELEV) with a Buy rating and announces Price Target of $7.5.

ELEV

Stocks That Hit 52-Week Lows On Friday

By Benzinga Insights

July 22, 2:51 PM

During Friday's session, 61 companies made new 52-week lows.

APDN

Raymond James Downgrades Sunstone Hotel Invts to Underperform

Related Posts

Morgan Stanley Initiates Coverage On RXO with Equal-Weight Rating, Announces Price Target of $20

Evaxion Announces Initial Phase 2 Clinical Data On Its Personalized Cancer Vaccine EVX-01

HC Wainwright & Co. Assumes Elevation Oncology at Buy, Announces Price Target of $7.5

Stocks That Hit 52-Week Lows On Friday